HomeRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Previous close
$9.51
Day range
$9.17 - $9.58
Year range
$4.97 - $16.75
Market cap
2.24B USD
Avg Volume
4.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 13.79M | 13.68% |
Operating expense | 31.30M | 44.21% |
Net income | -91.37M | -39.87% |
Net profit margin | -662.41 | -23.04% |
Earnings per share | -0.39 | -14.71% |
EBITDA | -88.86M | -36.77% |
Effective tax rate | 0.85% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 296.33M | -37.37% |
Total assets | 557.85M | -11.08% |
Total liabilities | 156.70M | -20.54% |
Total equity | 401.15M | — |
Shares outstanding | 237.66M | — |
Price to book | 5.63 | — |
Return on assets | -39.71% | — |
Return on capital | -49.80% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -91.37M | -39.87% |
Cash from operations | -102.30M | -39.53% |
Cash from investing | -6.65M | -24.59% |
Cash from financing | 13.90M | 623.05% |
Net change in cash | -95.28M | -24.16% |
Free cash flow | -63.23M | -50.59% |
About
Founded
2013
Headquarters
Website
Employees
500